Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological, Molecular, and DNA Methylation Analysis of Ossifying Fibromyxoid Tumors Delineates the ZC3H7B::BCOR Subset as a Distinct Entity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Perineurioma-like EMA-positive calvarial neoplasms: clinicopathological study of eight cases.

Histopathology·2026
Same author

A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous Transformation.

Head and neck pathology·2026
Same author

An Updated Conceptual Framework for Myoepithelial Tumors of Soft tissues and Bone: Toward a Molecularly Informed Classification.

Seminars in diagnostic pathology·2026
Same author

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Cancer cell·2026
Same author

Primary Pulmonary NUT Carcinoma: A Case Illustration of Therapeutic Challenges and Review of Emerging Targeted Therapies.

Case reports in oncological medicine·2026

Related Experiment Video

Updated: Jul 4, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.0K

Myxoid Pleomorphic Liposarcoma.

Josephine K Dermawan1

  • 1Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue L25, Cleveland, OH 44195, USA.

Surgical Pathology Clinics
|January 26, 2024
PubMed
Summary
This summary is machine-generated.

Myxoid pleomorphic liposarcoma (MPLPS) is an aggressive mediastinal tumor with worse survival than similar liposarcomas. It exhibits hybrid features of MRLPS and PLPS and unique molecular characteristics, including genome-wide loss of heterozygosity.

Keywords:
Loss of heterozygosityMyxoid pleomorphic liposarcomaTP53

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.9K

Related Experiment Videos

Last Updated: Jul 4, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.0K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.9K

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Myxoid pleomorphic liposarcoma (MPLPS) is a rare soft tissue sarcoma.
  • It predominantly affects the mediastinum and presents aggressive clinical behavior.

Purpose of the Study:

  • To characterize the clinical, histological, and molecular features of MPLPS.
  • To differentiate MPLPS from other liposarcoma subtypes.

Main Methods:

  • Histopathological analysis of tumor morphology.
  • Clinical data review including survival outcomes.
  • Molecular genetic analysis to identify distinct features.

Main Results:

  • MPLPS shows a predilection for the mediastinum across a wide age range.
  • Clinically, MPLPS demonstrates aggressive behavior and poorer survival compared to MRLPS and PLPS.
  • Histologically, it presents hybrid features of MRLPS and PLPS, with myxoid stroma, specific vasculature, and pleomorphic components.
  • Molecularly, MPLPS is characterized by genome-wide loss of heterozygosity, distinguishing it from other lipomatous tumors.

Conclusions:

  • MPLPS is a distinct liposarcoma subtype with aggressive behavior and unique clinicopathological and molecular features.
  • Understanding these characteristics is crucial for accurate diagnosis and improved patient management.